Kid Cards: Teaching Kids About Medicines

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2005 by Children's Mercy Hospital Kansas City.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Children's Mercy Hospital Kansas City
ClinicalTrials.gov Identifier:
NCT00127543
First received: August 5, 2005
Last updated: February 6, 2006
Last verified: December 2005
  Purpose

This study is being done to see if education about medicines directed toward children will improve their knowledge. The investigators also want to know if this knowledge lasts over time. Right now there are few medication instructional cards that are appropriate for children. Most of the medication cards provide information for adults. Some studies have shown that by teaching children directly, the children may take medicine at the right time for the right reason, have fewer side effects and know more about their medicine.

The purpose of this research study is to see if education about medication helps children learn more about their medicine and if this knowledge lasts.


Condition Intervention
Hemophilia
Sickle Cell Disease
Neoplasms
Blood Coagulation Disorders
Behavioral: Medication Education for Children

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: Kid Cards: Teaching Kids About Medicines

Resource links provided by NLM:


Further study details as provided by Children's Mercy Hospital Kansas City:

Primary Outcome Measures:
  • Develop medication cards appropriate for children
  • Develop a post-test to determine the effectiveness
  • Obtain data to support teaching children about medication

Secondary Outcome Measures:
  • Assess the clinical implications of this research

Estimated Enrollment: 50
Study Start Date: August 2005
Estimated Study Completion Date: December 2005
Detailed Description:

In 2004, then Surgeon General Carmona stated that a health literate individual is more apt to know the answer, when asked how to keep themselves well (AHRQ, 2004). There is a burgeoning movement among medical professionals to address health literacy. Teaching health information to children will empower them to actively participate in their current care and provide self-management skills that will assist them to keep themselves well throughout their lives. Currently, few medication administration instructional cards exist that are appropriate for children. Providing medication information that the child might understand may result in better administration compliance, fewer adverse effects and develop an individual that is knowledgeable regarding medications and appropriate administration. The purpose if this research is to develop medication administration cards, appropriate for children, which provide information on the most commonly used drugs among the Hematology/Oncology population.

The overall objective of this research is to develop medication informational cards for medications frequently used within the Hematology/Oncology pediatric population, and evaluate the effectiveness of these cards, by means of a pre- and post–test.

  Eligibility

Ages Eligible for Study:   7 Years to 11 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Between the ages of 7 – 11 years
  • Currently receiving disease management primarily coordinated through the Hematology/Oncology section
  • Receiving a medication identified as a variable for this study
  • Are able to assent and have a parent/guardian who is willing to consent to study participation
  • Suffer no apparent developmental difficulty that would prevent or make study participation difficult

Exclusion Criteria:

  • Individuals who cannot read or write English
  • Individuals who are known to be non-compliant with medication routine and/or adhering to follow-up visits.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00127543

Locations
United States, Missouri
Childrens Mercy Hospitals and Clinics
Kansas City, Missouri, United States, 64108
Sponsors and Collaborators
Children's Mercy Hospital Kansas City
Investigators
Principal Investigator: Heather E Curry, RN, MSN Childrens Mercy Hospitals and Clinics
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00127543     History of Changes
Other Study ID Numbers: 05 06-089E
Study First Received: August 5, 2005
Last Updated: February 6, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Mercy Hospital Kansas City:
Medication Education
Pediatric

Additional relevant MeSH terms:
Blood Coagulation Disorders
Hemostatic Disorders
Anemia, Sickle Cell
Anemia, Hemolytic, Congenital
Anemia, Hemolytic
Anemia
Hematologic Diseases
Hemoglobinopathies
Genetic Diseases, Inborn
Vascular Diseases
Cardiovascular Diseases
Hemorrhagic Disorders

ClinicalTrials.gov processed this record on September 16, 2014